111 related articles for article (PubMed ID: 13210728)
1. [Clinical studies on the new anticoagulant, marcoumar, and its antagonist, konakion (vitamin K1)].
GAGLIARDI L
Gynaecologia; 1954 Sep; 138(3):424-40. PubMed ID: 13210728
[No Abstract] [Full Text] [Related]
2. [Thromboembolism prophylaxis in surgical gynecology with a coumarin derivative and its antagonist vitamin K1].
ROTTGER H
Zentralbl Gynakol; 1955; 77(15):571-7. PubMed ID: 14397714
[No Abstract] [Full Text] [Related]
3. [Clinical study of the anticoagulant 3-(1-phenylpropyl)-4-hydroxycoumarin or marcoumar and of its antidote, vitamin K1].
GAGLIARDI L
Minerva Ginecol; 1954 Jan; 6(2):84-97. PubMed ID: 13154044
[No Abstract] [Full Text] [Related]
4. [Experimental research on the anticoagulant marcoumar (3-(1-phenyl-propyl)-4-hydroxy-coumarin) and its antagonist konakion (synthetic vitamin K1)].
JURGENS R
Schweiz Med Wochenschr; 1953 May; 83(20):471-5. PubMed ID: 13076081
[No Abstract] [Full Text] [Related]
5. [Phenylpropyl hydroxycoumarin as anticoagulant in obstetric and gynecological thrombophlebitis and its antidote, vitamin K1].
DE DOMINICIS E; ROLANDI L
Riv Ostet Ginecol Prat; 1955 Nov; 37(11):658-65. PubMed ID: 13281402
[No Abstract] [Full Text] [Related]
6. [Case reports & data on the use of phenylbutazone in the prevention & therapy of thrombophlebitis].
CAZZOLA D
Riv Ostet Ginecol Prat; 1958 Sep; 40(9):893-903. PubMed ID: 13592075
[No Abstract] [Full Text] [Related]
7. [Hypoprothrombinemia secondary to dicoumarin therapy; shock due to prolonged vitamin K2 therapy and perfusions and spectacular cure with vitamin K1].
SOULIER JP; SOULLARD J
Sang; 1952; 23(8):709-14. PubMed ID: 13004931
[No Abstract] [Full Text] [Related]
8. [Marcoumar in specific prevention of thrombosis].
BIRCHER J
Gynaecologia; 1954 Apr; 137(4):210-3. PubMed ID: 13174043
[No Abstract] [Full Text] [Related]
9. [Therapeutic possibilities of cutaneous application of an absorbable anticoagulant in therapy and prevention of phlebothrombosis in obstetrics and gynecology].
MALAGOLI F
Ann Ostet Ginecol; 1956; 78(3):431-6. PubMed ID: 13395202
[No Abstract] [Full Text] [Related]
10. Mechanism of action of anticoagulants: correlation between the inhibition of prothrombin synthesis and the regeneration of vitamin K1 from vitamin K1 epoxide.
Ren P; Stark PY; Johnson RL; Bell RG
J Pharmacol Exp Ther; 1977 Jun; 201(3):541-6. PubMed ID: 864593
[TBL] [Abstract][Full Text] [Related]
11. Intravenous emulsified vitamin K in the treatment of coumarin-induced hypoprothrombinemia.
STRAGNELL R
Am Heart J; 1952 Jul; 44(1):124-30. PubMed ID: 14933316
[No Abstract] [Full Text] [Related]
12. [Intravenous administration of vitamin K1 (konakion) as antidote to the anticoagulants of the dicumarol type].
KAPPELER R; KOLLER F
Schweiz Med Wochenschr; 1955 Jan; 85(3):62-4. PubMed ID: 14358604
[No Abstract] [Full Text] [Related]
13. [Effects of water-soluble vitamin K (menadione sodium bisulfite) and vitamin K1 on hypoprothrombinemia during anticoagulant therapy].
STURUP H
Ugeskr Laeger; 1954 Feb; 116(8):294-7. PubMed ID: 13146907
[No Abstract] [Full Text] [Related]
14. Vitamin K as antagonist to anticoagulants; the effect of synthetic vitamin K (menadione) and vitamin K1 in hypoprothrombinemia induced by dicoumarol, tromexan and phenylindanedione.
HILDEN T; MUNCK O
Scand J Clin Lab Invest; 1953; 5(4):361-5. PubMed ID: 13146038
[No Abstract] [Full Text] [Related]
15. The effectiveness of an oral vitamin K1 in controlling excessive hypoprothrombinemia during anticoagulant therapy.
COSGRIFF SW
Ann Intern Med; 1956 Jul; 45(1):14-22. PubMed ID: 13340565
[No Abstract] [Full Text] [Related]
16. [Vitamin K1 and hypoprothrombinemias in hepatic diseases].
TAINE B; JUVANON J
Lyon Med; 1959 Jul; 91():111-26. PubMed ID: 13836612
[No Abstract] [Full Text] [Related]
17. The effect of intravenous injection of emulsified vitamin K1 on the hypoprothrombinemia induced by tromexan.
VAN BUSKIRK WC
N Engl J Med; 1953 Jan; 248(2):57-8. PubMed ID: 13002683
[No Abstract] [Full Text] [Related]
18. The response of dicumarol-induced hypoprothrombinemia to vitamin K.
REHBEIN A; JARETZKI A; HABIF DV
Ann Surg; 1952 Apr; 135(4):454-69. PubMed ID: 14915438
[No Abstract] [Full Text] [Related]
19. [The therapeutic use of a new anticoagulant, marcoumar].
DEUTSCH E; HUEBER EF; MAYER E; WOHLRAB K
Klin Med Osterr Z Wiss Prakt Med; 1954 Feb; 9(2):49-60. PubMed ID: 13164206
[No Abstract] [Full Text] [Related]
20. Vitamin K1 in the control of phenylindanedione-induced anticoagulant therapy.
ENGLISH A; TOWNSEND SR; CAMERON DG
Can Med Assoc J; 1955 Feb; 72(3):184-5. PubMed ID: 13231011
[No Abstract] [Full Text] [Related]
[Next] [New Search]
